QA: Intra-Cellular Therapies Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567514_2023_Intra_Cellular_Therapies_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001567514, Intra-Cellular Therapies Inc.

  xvar xval
0 AssetsCurrent 737,957,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,913,000
3 remainder_Assets 14,910,000
4 LiabilitiesCurrent 83,236,000
5 LiabilitiesNoncurrent 15,474,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 358,782,000
9 ResearchAndDevelopmentExpense 134,715,000
10 remainder_Expenses 20,449,000
11 remainder_Revenues 250,314,000
12 remainder_NetIncome 7,376,000
13 remainder_ComprehensiveNetIncome -3,826,000
  yvar yval
0 Assets 754,780,000
1 Liabilities 98,710,000
2 Expenses 513,946,000
3 Revenues 250,314,000
4 StockholdersEquity 656,070,000
5 NetIncome -256,256,000
6 ComprehensiveNetIncome -258,169,000
7 BaseVar 814,476,000
8 EconomicCapitalRatio 2.04

Edgar->Model Mapping

Feature Distribution

Change over Time